|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
20,430,000 |
Market
Cap: |
1.37(B) |
Last
Volume: |
2,387,520 |
Avg
Vol: |
2,380,888 |
52
Week Range: |
$38.04 - $69.69 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile ANI Pharmaceuticals is a bio-pharmaceutical company focused on developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Co.'s products include: Candesartan Hydrochlorothiazide, Fenofibrate, Fluvoxamine, Hydrocortisone Enema, Lithium Carbonate ER, Mesalamine, Propranolol ER, Terbutaline, and Vancomycin.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
320,801 |
421,551 |
1,262,027 |
1,480,093 |
Total Sell Value |
$21,062,080 |
$26,516,522 |
$74,515,877 |
$82,888,946 |
Total People Sold |
9 |
9 |
12 |
12 |
Total Sell Transactions |
28 |
40 |
87 |
90 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Simes Stephen M |
Vice Chair, Pres. & CEO |
|
2004-10-22 |
4 |
GD |
$0.00 |
$0 |
I/I |
650 |
69,491 |
|
- |
|
Rosenow Edward C III |
Director |
|
2004-10-15 |
4/A |
OE |
$2.85 |
$14,250 |
D/D |
5,000 |
17,539 |
|
- |
|
Rosenow Edward C III |
Director |
|
2004-10-15 |
4 |
OE |
$2.85 |
$21,375 |
D/D |
7,500 |
20,039 |
|
- |
|
Holubow Fred |
Director |
|
2004-10-14 |
4 |
D |
$9.85 |
$21,384 |
D/D |
(2,171) |
69,883 |
|
- |
|
Holubow Fred |
Director |
|
2004-10-14 |
4 |
OE |
$2.85 |
$21,375 |
D/D |
7,500 |
72,054 |
|
- |
|
Bell Steven J |
VP, Research, Pre-Clinical Dev |
|
2004-10-14 |
4 |
S |
$10.01 |
$25,025 |
D/D |
(2,500) |
4,375 |
|
- |
|
Bell Steven J |
VP Research & Clin. Develop. |
|
2004-10-12 |
4 |
S |
$9.85 |
$24,625 |
D/D |
(2,500) |
6,875 |
|
- |
|
Mangano Ross J |
Director |
|
2004-10-11 |
4 |
OE |
$2.85 |
$21,375 |
D/D |
7,500 |
36,956 |
|
- |
|
Perceptive Advisors Llc |
10% Owner |
|
2004-10-08 |
4 |
B |
$9.87 |
$156,857 |
I/I |
15,900 |
1,973,550 |
1.5 |
- |
|
Morgenstern Victor A |
Director |
|
2004-10-08 |
4 |
OE |
$2.85 |
$21,375 |
D/D |
7,500 |
404,071 |
|
- |
|
Bell Steven J |
VP Research & Clin. Develop. |
|
2004-10-08 |
4 |
S |
$9.80 |
$44,125 |
D/D |
(4,500) |
9,375 |
|
- |
|
Bell Steven J |
VP Research & Clin. Develop. |
|
2004-10-08 |
4 |
OE |
$2.85 |
$35,625 |
D/D |
12,500 |
13,875 |
|
- |
|
Perceptive Advisors Llc |
10% Owner |
|
2004-10-07 |
4 |
B |
$10.11 |
$101,071 |
I/I |
10,000 |
1,958,650 |
1.5 |
- |
|
Perceptive Advisors Llc |
10% Owner |
|
2004-10-06 |
4 |
B |
$9.90 |
$99,013 |
I/I |
10,000 |
1,949,650 |
1.5 |
- |
|
Perceptive Advisors Llc |
10% Owner |
|
2004-10-05 |
4 |
B |
$9.90 |
$173,247 |
I/I |
17,500 |
1,940,650 |
1.5 |
- |
|
Perceptive Advisors Llc |
10% Owner |
|
2004-10-04 |
4 |
B |
$9.72 |
$140,950 |
I/I |
14,500 |
1,924,850 |
1.5 |
- |
|
Perceptive Advisors Llc |
10% Owner |
|
2004-10-01 |
4 |
B |
$9.59 |
$206,185 |
I/I |
21,500 |
1,911,750 |
1.5 |
- |
|
Perceptive Advisors Llc |
10% Owner |
|
2004-09-30 |
4 |
B |
$8.96 |
$89,645 |
I/I |
10,000 |
1,892,350 |
1.5 |
- |
|
Perceptive Advisors Llc |
10% Owner |
|
2004-09-14 |
4 |
B |
$7.69 |
$188,287 |
I/I |
24,500 |
1,883,350 |
1.5 |
- |
|
Perceptive Advisors Llc |
10% Owner |
|
2004-09-13 |
4 |
B |
$7.17 |
$185,654 |
I/I |
25,900 |
1,861,250 |
1.5 |
- |
|
Perceptive Advisors Llc |
10% Owner |
|
2004-09-09 |
4 |
B |
$6.85 |
$32,195 |
I/I |
4,700 |
1,837,850 |
1.5 |
- |
|
Perceptive Advisors Llc |
10% Owner |
|
2004-08-31 |
4 |
B |
$6.84 |
$61,563 |
I/I |
9,000 |
1,833,550 |
1.5 |
- |
|
Perceptive Advisors Llc |
10% Owner |
|
2004-08-30 |
4 |
B |
$6.84 |
$68,374 |
I/I |
10,000 |
1,824,550 |
1.5 |
- |
|
Perceptive Advisors Llc |
10% Owner |
|
2004-08-19 |
4 |
B |
$5.84 |
$40,328 |
I/I |
6,900 |
12,450 |
1.5 |
- |
|
Perceptive Advisors Llc |
10% Owner |
|
2004-08-18 |
4 |
B |
$5.83 |
$262,139 |
I/I |
45,000 |
11,750 |
1.5 |
- |
|
719 Records found
|
|
Page 26 of 29 |
|
|